49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

      Science (New York, N.Y.)
      Acute-Phase Proteins, Animals, Antibodies, Monoclonal, immunology, Antigens, CD, Antigens, CD14, Antigens, CD18, Antigens, Differentiation, Myelomonocytic, Carrier Proteins, Erythrocytes, Leukocytes, Lipopolysaccharides, Macrophages, Membrane Glycoproteins, Receptors, Leukocyte-Adhesion, Sheep, Tumor Necrosis Factor-alpha, biosynthesis

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Leukocytes respond to lipopolysaccharide (LPS) at nanogram per milliliter concentrations with secretion of cytokines such as tumor necrosis factor-alpha (TNF-alpha). Excess secretion of TNF-alpha causes endotoxic shock, an often fatal complication of infection. LPS in the bloodstream rapidly binds to the serum protein, lipopolysaccharide binding protein (LBP), and cellular responses to physiological levels of LPS are dependent on LBP. CD14, a differentiation antigen of monocytes, was found to bind complexes of LPS and LBP, and blockade of CD14 with monoclonal antibodies prevented synthesis of TNF-alpha by whole blood incubated with LPS. Thus, LPS may induce responses by interacting with a soluble binding protein in serum that then binds the cell surface protein CD14.

          Related collections

          Author and article information

          Comments

          Comment on this article